This page explains why the GOAL 3 Knowledge Hub exists, what you will find in it, and how to find your way around.

<aside>

Why we share this openly

GOAL 3 is a Dutch social enterprise working with hospitals in sub-Saharan Africa, where our IMPALA digital health system helps health workers monitor critically ill children and newborns and act on deterioration earlier. We believe that anyone deciding whether to fund, buy, implement or study IMPALA should be able to check our work for themselves.

This hub is where we make that possible. It brings together our evidence, including results that are uncertain or not statistically significant; how our model works and what IMPALA costs; how we are governed; and the risks and limitations we see. Where evidence is limited, we say so, and where a figure is modelled or an internal calculation rather than observed, we aim to label it.

We keep this as one maintained source instead of scattered documents and slide decks, so that funders, partners, researchers and external reviewers work from the same information we use ourselves.

Who this hub is for

• Funders and donors assessing GOAL 3 or the GOAL 3 Foundation
• Ministries of health, hospitals and implementation partners
• Researchers and external evaluators
• Board members and advisors
• GOAL 3 staff, country teams, interns and new team members

This page was last updated: October 7, 2026

</aside>

<aside>

How to use this Knowledge Hub

</aside>

Start with the question you have:

• New to GOAL 3?
  • Read Our organisation: GOAL 3 for our story, the problem we work on and our Theory of Change,
  • then Our product: IMPALA.
• Assessing impact or cost-effectiveness?
  • Start with IMPALA’s impact at a glance,
  • then the Evidence Summary Dashboard and
  • the Rethink Priorities Report, an external review of IMPALA's cost-effectiveness.
• Looking at costs and funding?
  • See The costs of IMPALA,
  • thenFunding impact: what one implementation delivers and
  • the Absorption capacity.
• Planning to implement IMPALA?
  • See Our product: IMPALA for the monitor, platform and service model, and
  • then How we work.
• Looking for the underlying studies?
  • The Research Database lists the studies and reports we draw on, with links.
• Want to know the underlying risks and potential limitations?
  • See Risks, limitations and safeguards.

Reading our evidence

The Evidence Summary Dashboard breaks IMPALA's impact into separate claims (C1–C13), from technical reliability to mortality and cost-effectiveness. Each claim has an evidence grade, a synthesis, its sources and links to related claims. Most outcome studies so far were conducted or co-authored by GOAL 3, and none is randomised yet; the dashboard notes this where it matters.

<aside>

About GOAL 3

</aside>

Website: https://www.goal3.org/

LinkedIn: https://www.linkedin.com/company/goal3/

Email: [email protected]

Head office GOAL 3

Grasso Building; Room KA1.14 Parallelweg 27 5223 AL, 's-Hertogenbosch The Netherlands

Office GOAL 3 Rwanda

Norrsken Kigali House 1 KN 78 ST Kigali Rwanda

Finding your way

Pages link to each other, so you can move from strategy to costs to the underlying studies. Each page shows when it was last updated and the hub is updated regularly. If something looks outdated, out of place, or unclear, please email [email protected].